<p>Mice treated with either AAV-scFv6H4 or AAV-scFv7F9 showed significantly lower brain METH concentrations (a) and significantly higher serum concentrations of METH (b) than the saline-treated mice (*, p < 0.05; #, p < 0.001). There was also a significant decrease in AMP brain concentrations (c) in the AAV-scFv treated groups compared to control mice but no difference in serum AMP concentrations (d). Points are shown as mean ± SEM (n = 3–4 per group).</p
<p>On days 4, 6, and 8, mice were treated with vehicle (10 ml/kg) or METH (1 mg/kg), and then confin...
<p>(a) Open field locomotor activity after challenge with METH (2.5 mg/kg). Locomotion was measured ...
<p><b>A)</b> MBL-A concentrations were reduced after DR (15.4 μg/ml) and FA (12.4 μg/ml) as compared...
<p>On day 0, mice were injected with PBS (control treatment), AAV-scFv6H4, or AAV-scFv7F9. Serum scF...
<p>Fifty days after AAV-scFv treatment, mice were injected <i>sc</i> with 1 mg/kg METH. Blood sample...
<p>(A) Systemic injection (s.c.) of both doses of PD149163 resulted in a significant decrease in nos...
<p><sup>3</sup>H-METH binding was determined by equilibrium dialysis. Purified scFv7F9 (4 μg/ml) was...
<p>(A) METH injection reduced THir in +/+ and +/− mice following one time binge METH exposure (1X ME...
<p>Mice were treated daily for 5 consecutive days with vehicle (10 ml/kg) or METH (3 mg/kg). Seven d...
<p>Relative locomotor activity and prepulse inhibition after acute (A, B, C) and chronic (D, E, F) a...
<p><b>A)</b> Preference score in WT and mGlu5 KO mice at habituation and test. Preference score is d...
<p>Mice were administered METH, KA or TMT with saline (0.9%) as a control and were killed by focused...
<p>Extracellular DA concentration was measured using chronoamperometry after local application of lo...
<p>Representative images of the striatum from brains of animals treated with either VEH (A, E), MOD ...
<p>Seven-week-old C57BL/6J male mice were treated with an intraperitoneal injection (i.p.) of METH (...
<p>On days 4, 6, and 8, mice were treated with vehicle (10 ml/kg) or METH (1 mg/kg), and then confin...
<p>(a) Open field locomotor activity after challenge with METH (2.5 mg/kg). Locomotion was measured ...
<p><b>A)</b> MBL-A concentrations were reduced after DR (15.4 μg/ml) and FA (12.4 μg/ml) as compared...
<p>On day 0, mice were injected with PBS (control treatment), AAV-scFv6H4, or AAV-scFv7F9. Serum scF...
<p>Fifty days after AAV-scFv treatment, mice were injected <i>sc</i> with 1 mg/kg METH. Blood sample...
<p>(A) Systemic injection (s.c.) of both doses of PD149163 resulted in a significant decrease in nos...
<p><sup>3</sup>H-METH binding was determined by equilibrium dialysis. Purified scFv7F9 (4 μg/ml) was...
<p>(A) METH injection reduced THir in +/+ and +/− mice following one time binge METH exposure (1X ME...
<p>Mice were treated daily for 5 consecutive days with vehicle (10 ml/kg) or METH (3 mg/kg). Seven d...
<p>Relative locomotor activity and prepulse inhibition after acute (A, B, C) and chronic (D, E, F) a...
<p><b>A)</b> Preference score in WT and mGlu5 KO mice at habituation and test. Preference score is d...
<p>Mice were administered METH, KA or TMT with saline (0.9%) as a control and were killed by focused...
<p>Extracellular DA concentration was measured using chronoamperometry after local application of lo...
<p>Representative images of the striatum from brains of animals treated with either VEH (A, E), MOD ...
<p>Seven-week-old C57BL/6J male mice were treated with an intraperitoneal injection (i.p.) of METH (...
<p>On days 4, 6, and 8, mice were treated with vehicle (10 ml/kg) or METH (1 mg/kg), and then confin...
<p>(a) Open field locomotor activity after challenge with METH (2.5 mg/kg). Locomotion was measured ...
<p><b>A)</b> MBL-A concentrations were reduced after DR (15.4 μg/ml) and FA (12.4 μg/ml) as compared...